HBK Investments L P Invests $1.37 Million in Omada Health, Inc. $OMDA

HBK Investments L P bought a new stake in Omada Health, Inc. (NASDAQ:OMDA) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 75,000 shares of the company’s stock, valued at approximately $1,372,000. HBK Investments L P owned about 0.29% of Omada Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of OMDA. XTX Topco Ltd bought a new position in Omada Health in the second quarter valued at approximately $414,000. Eisler Capital Management Ltd. acquired a new stake in shares of Omada Health in the 2nd quarter valued at approximately $545,000. Geode Capital Management LLC bought a new position in shares of Omada Health in the second quarter valued at $637,000. Teacher Retirement System of Texas acquired a new position in Omada Health during the second quarter worth $640,000. Finally, Franklin Resources Inc. acquired a new position in Omada Health during the second quarter worth $2,695,000.

Omada Health Price Performance

Shares of NASDAQ:OMDA opened at $18.73 on Monday. Omada Health, Inc. has a 12-month low of $14.14 and a 12-month high of $28.40. The stock’s 50 day moving average price is $22.57.

Wall Street Analysts Forecast Growth

A number of analysts have commented on OMDA shares. Robert W. Baird started coverage on shares of Omada Health in a research note on Friday, September 5th. They issued a “neutral” rating and a $24.00 price target for the company. BMO Capital Markets assumed coverage on shares of Omada Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $27.00 target price for the company. Canaccord Genuity Group boosted their price target on Omada Health from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Needham & Company LLC upped their price objective on Omada Health from $26.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a research note on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Omada Health Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.